Observational studyInternational journal of clinical practice2014

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions.

G Adler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.